- The original event time is:
- Friday, March 26, 2021 - 13:00 - 15:15 Amsterdam time (CET)
Date
- , -
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Twitter
- Public stakeholder meeting: approval, safety monitoring and impact of COVID-19 vaccines in the EU
Event summary
This third public meeting updated EU citizens about the continued assessment, approval and safety monitoring of COVID-19 vaccines, and their expected impact at community level.
It covered:
- COVID-19 vaccines approved in the EU and those currently under review;
- post-authorisation activities, including emerging safety data since EU authorisation of the first COVID-19 vaccines;
- ongoing work to address new variants;
- the expected impact of COVID-19 vaccination on our society;
- transparency and the publication of clinical data for COVID-19 vaccines.
The event also allowed the public and stakeholders to further inform EMA of their needs, expectations and any concerns.
Video recordings
Full video recording
Update on approved and candidate COVID-19 vaccines in the EU, Marco Cavaleri (EMA)
Vaccines safety monitoring – update on emerging data since EU authorisations, Peter Arlett (EMA)
Expected impact of COVID-19 vaccination in the European Union, Edoardo Colzani (ECDC)
Transparency and publication of clinical data for COVID-19 vaccines, Melanie Carr (EMA)